MedPath

Prospective study of CIPN in patients undergoing gemcitabine plus nab-PTX for pancreatic cancer

Not Applicable
Recruiting
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000045287
Lead Sponsor
Graduate School of Medicine, The University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Judgement by doctors

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath